HelioLiver LDT now available to order through Quest Diagnostics
Helio Genomics Our Story Technology Research Our Team Blog & Interviews News & Media HelioLiver LDT Overview The Science For Providers The HelioLiver Test Clinical Evidence FAQ For Patients Overview Early Detection Testing with HelioLiver Resources FAQ Contact
Clinical researchers collaborating in a cancer research laboratory
Research & Pipeline

Clinical Trials and Collaborations

Learn how Helio is advancing cancer research through clinical studies and collaborating with partners.

Clinical Research Multi-Centre Studies US & China Trials
Collaboration Network

Our Partners in Health

We are proud to collaborate with organisations that share our mission and values. We are currently partnering with leading medical institutions and research centres to advance early cancer detection research.

Helio Genomics Helio Genomics
Academic Research
Cancer Centers
Clinical Networks
Healthcare Systems
Research Institutions
Clinical Research Pipeline

Our Current Studies

We are dedicated to making accurate early detection tests available for more cancers. Helio is currently engaged in multiple pivotal, multi-centre trials in the US and China.

ENCORE

Completed

A study to define the performance characteristics of the HelioLiver Test within a study population of subjects diagnosed with liver cancer at various stages (I to IV).

NCT05059665 View Study

CLiMB

Completed

A multi-centre, prospective study conducted in the US to compare the sensitivity and specificity of the HelioLiver Test with ultrasound within a population at high risk of HCC due to liver cirrhosis.

NCT03694600 View Study

FAST

Ongoing

A prospective R01 study sponsored by the NCI in collaboration with Mount Sinai and other US medical institutions to evaluate novel screening modalities and biomarkers.

NCT04539717 View Study

ELITE

Ongoing

A multi-centre, prospective study conducted in the US to discover new biomarkers for various cancer types, including colon, lung, and breast.

NCT05181826 View Study

LIVER-1

Ongoing

A multi-centre, prospective study conducted in the US to develop and validate the Helio Multi-Analyte Blood Test within a population at high risk for HCC due to liver disease or cirrhosis, and in HCC-positive subjects.

NCT05199259 View Study
Researchers in a clinical collaboration meeting
Partner With Us

Let's Advance Cancer Research — Together

Helio is looking to partner with research and clinical organisations that see patients who have cancer or are at high risk of developing it. Leave us a message if you are interested in collaborating with us on upcoming clinical trials and research.